Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Valneva SE ADR stock

Learn how to easily invest in Valneva SE ADR stock.

The vaccine-focused biotech company Valneva is prepraring for a potential listing of its American Depositary Share (ADS). This means that while the company is headquartered in France, you'll be able to easily buy shares using a US brokerage.

How to buy shares in Valneva SE ADR

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VALN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Valneva SE ADR stock price (NASDAQ: VALN)

Use our graph to track the performance of VALN stocks over time.

Valneva SE ADR shares at a glance

Information last updated 2022-10-04.
Latest market close$11.53
52-week range$9.77 - $67.84
50-day moving average $17.17
200-day moving average $27.94
Wall St. target price$31.40
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.49

Buy Valneva SE ADR shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Valneva SE ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Valneva SE ADR price performance over time

Historical closes compared with the close of $11.53 from 2022-10-05

1 week (2022-09-29) 17.65%
1 month (2022-09-06) -27.84%
3 months (2022-07-06) -46.40%
6 months (2022-04-06) -67.10%
1 year (2021-10-06) -59.20%
2 years (2020-10-02) N/A
3 years (2019-10-02) N/A
5 years (2017-10-02) N/A

Valneva SE ADR financials

Revenue TTM $304.4 million
Gross profit TTM $-13,118,000
Return on assets TTM -18.5%
Return on equity TTM -186.14%
Profit margin -52.07%
Book value $1.59
Market capitalisation $683.7 million

TTM: trailing 12 months

Valneva SE ADR share dividends

We're not expecting Valneva SE ADR to pay a dividend over the next 12 months.

You may also wish to consider:

Valneva SE ADR share price volatility

Over the last 12 months, Valneva SE ADR's shares have ranged in value from as little as $9.77 up to $67.84. A popular way to gauge a stock's volatility is its "beta".

VALN.US volatility(beta: 0.94)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Valneva SE ADR's is 0.9406. This would suggest that Valneva SE ADR's shares are less volatile than average (for this exchange).

To put Valneva SE ADR's beta into context you can compare it against those of similar companies.

Valneva SE ADR overview

Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium; and VLA2001, a vaccine candidate against SARS-CoV-2. The company also develops VLA15, a vaccine candidate that has completed Phase II clinical trial against Borrelia; and VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, other European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is headquartered in Saint-Herblain, France.

Frequently asked questions

What percentage of Valneva SE ADR is owned by institutions?
Currently 0.114% of Valneva SE ADR shares are held by institutions.
How many people work for Valneva SE ADR?
Latest data suggests 700 work at Valneva SE ADR.
When does the fiscal year end for Valneva SE ADR?
Valneva SE ADR's fiscal year ends in December.
Where is Valneva SE ADR based?
Valneva SE ADR's address is: 6 rue Alain Bombard, Saint-Herblain, France, 44800
What is Valneva SE ADR's ISIN number?
Valneva SE ADR's international securities identification number is: US92025Y1038

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site